Kaiser Permanente | GenomeWeb

Kaiser Permanente

The healthcare provider plans to build a large biobank to conduct precision medicine research based on genomics, lifestyle, and environmental factors. 

The Kaiser Permanente Northwest researchers focused on patient preferences, their ability to handle unexpected results, and the time required for genetic counseling.

The latest analysis of CYP2C19 genotyping to guide antiplatelet therapy tries to address cost questions from the vantage of a payor or large healthcare system.

The three papers published in Genetics will provide the basis for future investigations into the links between genetics, environment, and disease risk.

The partners will conduct a study using electronic medical records to find new best practices for the diagnosis and treatment of ovarian cancer.

A $4.6 million Simons Foundation grant will fund enrollment and initial data collection, but additional resources are necessary for genetic analysis and hypothesis generation.

With $4.6M in funding from the Simons Foundation, Kaiser will collect data from 5,000 families in Northern California.

The firm will use samples and data from Kaiser Permanente hospitals to test its metastatic breast cancer patient-stratification molecular diagnostic assays.

NEW YORK (GenomeWeb) – Pacific Edge announced on Wednesday an agreement with the Southern California Permanente Medical Group for the evaluation of Pacific Edge's gene expression-based test for the detection of bladder cancer.

NEW YORK (GenomeWeb News) – The Melanoma Research Alliance and the Hidary Foundation have awarded $1 million to fund two new genome sequencing-focused research projects aimed at understanding the genetic drivers of acral melanoma, MRA said today.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.